Bruce F. Farber

2.9k total citations · 1 hit paper
58 papers, 2.1k citations indexed

About

Bruce F. Farber is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Bruce F. Farber has authored 58 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 21 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Bruce F. Farber's work include Antimicrobial Resistance in Staphylococcus (13 papers), Infective Endocarditis Diagnosis and Management (9 papers) and Infection Control in Healthcare (6 papers). Bruce F. Farber is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (13 papers), Infective Endocarditis Diagnosis and Management (9 papers) and Infection Control in Healthcare (6 papers). Bruce F. Farber collaborates with scholars based in United States and United Kingdom. Bruce F. Farber's co-authors include R C Moellering, Mark H. Kaplan, George M. Eliopoulos, Richard P. Wenzel, Donna Armellino, Judith Brody, Adolf W. Karchmer, Carole Brennen, Erfan Hussain and Donald L. Kaiser and has published in prestigious journals such as New England Journal of Medicine, JAMA and Diabetes.

In The Last Decade

Bruce F. Farber

55 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981

1983 342 citations Bruce F. Farber et al. profile →

Peers

Countries citing papers authored by Bruce F. Farber

Since Specialization

Citations

This map shows the geographic impact of Bruce F. Farber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce F. Farber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce F. Farber more than expected).

Fields of papers citing papers by Bruce F. Farber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce F. Farber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce F. Farber. The network helps show where Bruce F. Farber may publish in the future.

Co-authorship network of co-authors of Bruce F. Farber

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce F. Farber. A scholar is included among the top collaborators of Bruce F. Farber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce F. Farber. Bruce F. Farber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hospital-Acquired Bloodstream Infections in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019): Association With Immunosuppressive Therapies 2021 ·Open Forum Infectious Diseases ·Akshay Khatri, Prashant Malhotra, (unknown), Angela Kim, Michael Oppenheim, (unknown), Tai C. Chen, (unknown), Ilan Berlinrut, (unknown), (unknown), David Hirschwerk, Marcia Epstein, Bruce F. Farber	22
2	Cooling Blankets in Hospitalized Patients: Time to Reevaluate 2021 ·The American Journal of the Medical Sciences ·(unknown), Prashant Malhotra, (unknown), (unknown), (unknown), (unknown), Rebecca M. Schwartz, Bruce F. Farber	0
3	Streamlining Electronic Medical Records: Remove the Copy-Forward Option 2020 ·Southern Medical Journal ·Bruce F. Farber, Vasupradha Vethantham, Prashant Malhotra	1
4	Estimating the predictive value of negative severe acute respiratory coronavirus virus 2 (SARS-CoV-2) results: A prospective study 2020 ·Infection Control and Hospital Epidemiology ·David Hirschwerk, (unknown), Martin Lesser, Bruce F. Farber, James M. Crawford, Karina W. Davidson, Gregory J. Berry, Elizabeth Smith, (unknown), (unknown), Thomas McGinn	1
5	Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area 2020 ·JAMA ·(unknown), Grace Sembajwe, Mark Jarrett, Bruce F. Farber, Tylis Y. Chang, Thomas McGinn, Karina W. Davidson	160
6	Multifocal extracranial mycotic aneurysms in a patient with endocarditis 2020 ·IDCases ·Alexander M. Spring, Michael A. Catalano, Bruce F. Farber, Kambhampaty Krishnasastry, Pey‐Jen Yu	3
7	Modifying the risk: Once-a-day bathing “at risk” patients in the intensive care unit with chlorhexidine gluconate 2014 ·American Journal of Infection Control ·Donna Armellino, (unknown), (unknown), (unknown), Ann Eichorn, Robert A. Silverman, David Hirschwerk, Bruce F. Farber	8
8	Replicating changes in hand hygiene in a surgical intensive care unit with remote video auditing and feedback 2013 ·American Journal of Infection Control ·Donna Armellino, (unknown), (unknown), (unknown), (unknown), Erfan Hussain, Bruce F. Farber	45
9	Mechanism of Salicylate‐Mediated Inhibition of Biofilm inStaphylococcus epidermidis 1998 ·The Journal of Infectious Diseases ·E Müller, (unknown), (unknown), Bruce F. Farber	64
10	Methicillin-resistant Staphylococcal enterocolitis 1998 ·The American Journal of Medicine ·(unknown), Nicholas Chiorazzi, Bruce F. Farber	22
11	Skin and Mucous Membrane Contacts With Blood During Surgical Procedures: Risk and Prevention 1995 ·Infection Control and Hospital Epidemiology ·Jerome I. Tokars, David H. Culver, Meryl H. Mendelson, Edward P. Sloan, Bruce F. Farber, Denise J. Fligner, Mary E. Chamberland, Ruthanne Marcus, Penny S. McKibben, David M. Bell	51
12	Multidrug-Resistant Enterococcus faecium 1994 ·Drugs ·(unknown), Bruce F. Farber	75
13	Risk of human immunodeficiency virus infection among emergency department workers 1993 ·The American Journal of Medicine ·Ruthanne Marcus, David H. Culver, David M. Bell, Pamela U. Srivastava, Meryl H. Mendelson, Robert J. Zalenski, Bruce F. Farber, Denise J. Fligner, Joseph M. Hassett, Thomas C. Quinn, Charles A. Schable, Edward P. Sloan, (unknown), Gabor D. Kelen	67
14	The Use of Nonsteroidal Antiinflammatory Drugs to Prevent Adherence of Staphylococcus epidermidis to Medical Polymers 1992 ·The Journal of Infectious Diseases ·Bruce F. Farber, (unknown)	50
15	Disposal of Medical Waste: The New York Experience Under the Medical Tracking Act 1991 ·Infection Control and Hospital Epidemiology ·Bruce F. Farber	0
16	Enterococcal Endocarditis: A Comparison of Prosthetic and Native Valve Disease 1990 ·Clinical Infectious Diseases ·Louis B. Rice, Stephen B. Calderwood, George M. Eliopoulos, Bruce F. Farber, Adolf W. Karchmer	74
17	Staphylococcus epidermidis Extracted Slime Inhibits the Antimicrobial Action of Glycopeptide Antibiotics 1990 ·The Journal of Infectious Diseases ·Bruce F. Farber, Mark H. Kaplan, (unknown)	155
18	Antipsoriatic effects of zidovudine in human immunodeficiency virus-associated psoriasis 1989 ·Journal of the American Academy of Dermatology ·Mark H. Kaplan, Neil S. Sadick, JOSHUA M. WIEDER, Bruce F. Farber, (unknown)	61
19	Current Status of Hydatid Disease 1988 ·Digestive Diseases ·Tsieh Sun, Marlene Rackson, Bruce F. Farber	4
20	Infection control in intensive care 1987 ·Churchill Livingstone eBooks ·Bruce F. Farber	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact